Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment
1
x
$
30.00
Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy
1
x
$
30.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
1
x
$
15.00
Psychopharmacology Bulletin VOL 36 Supplement No. 3 - Full Issue Stacked PDF
1
x
$
60.00
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
1
x
$
30.00
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
1
x
$
0.00
View Cart
Checkout
Home
mood-disorders
“Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Sale!
VOL 3 No. 7 Full Issue – July 2001
$
30.00
Original price was: $30.00.
$
20.00
Current price is: $20.00.
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 3, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
$
0.00
Add to cart
Details
Psychopharmacology Bulletin VOL 38 Supplement No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression
$
30.00
Add to cart
Details
Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
$
30.00
Add to cart
Details
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Gender-Specific Differences in Depression and Treatment Response
$
30.00
Add to cart
Details
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
The Red Book of Mood Disorders in Women: An Evidence-Based Treatment Guide
$
30.00
Add to cart
Details
Page load link
Go to Top
